A multicenter phase II trial evaluating the efficacy of bevacizumab plus mFOLFOX6 for R0 surgical resection in advanced colorectal liver metastases harboring mutant-type KRAS: NEXTO-mt trial.
暂无分享，去创建一个
K. Hasegawa | T. Takayama | N. Kokudo | A. Saiura | Y. Mise | Y. Inoue | N. Akamatsu | Y. Kishi | J. Arita | Y. Nishioka | K. Suyama | T. Noie | M. Oba | G. Watanabe | Y. Takahashi